Acute Myelocytic Leukemia
Showing 1 - 25 of >10,000
Acute Myelocytic Leukemia Trial in Hefei (Unrelated umbilical cord blood, Venetoclax, Decetabine)
Recruiting
- Acute Myelocytic Leukemia
- Unrelated umbilical cord blood
- +3 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Oct 27, 2023
Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)
Completed
- Acute Myelocytic Leukemia
- Myelodysplastic Syndrome
-
Berlin, Germany
- +10 more
Nov 12, 2021
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Acute Myeloid Leukemia Trial in Hangzhou (RC1012 injection (allo-DNT cells))
Recruiting
- Acute Myeloid Leukemia
- RC1012 injection (allo-DNT cells)
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University
Aug 3, 2022
Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)
Completed
- Leukemia, Myelocytic, Acute
- CD34+ selection with CliniMACS device
-
Duarte, California
- +7 more
Oct 21, 2021
Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (HSC835)
Completed
- Acute Myelocytic Leukemia
- +12 more
- HSC835
-
Minneapolis, MinnesotaNovartis Investigative Site
Dec 9, 2020
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem
Terminated
- Leukemia, Myeloid, Acute
- +8 more
- Mesenchymal stem cells
- Isotonic solution
-
Edeghem, Antwerpen, Belgium
- +9 more
Aug 31, 2021
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial run by the NHLBI (Miltenyi
Completed
- Leukemia, Myeloid, Acute
- +2 more
- Miltenyi Magnetic cell sorter for CD3
-
Bethesda, MarylandNational Institutes of Health
Oct 7, 2020
Leukemia, Myelocytic, Acute Trial in Czechia, Germany (study part 1 - dose daunorubicin, induction cycles)
Recruiting
- Leukemia, Myelocytic, Acute
- study part 1 - dose daunorubicin
- induction cycles
-
Brno, Czechia
- +39 more
Sep 6, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti Tim-3/CD123 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 4, 2023
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding
Completed
- Leukemia, Acute
- (no location specified)
Jul 23, 2023
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 23, 2023
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)
Recruiting
- Acute Myeloid Leukemia Refractory
- NP137
- +2 more
-
Lyon, FranceCentre Léon Bérard
Nov 30, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023